Qiankun Quan
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.
Journal: Experimental and therapeutic medicine
Published: May 08, 2023
Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Journal: Molecular medicine reports
Published: February 19, 2020
CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Journal: Journal of Alzheimer's disease : JAD
Published: August 13, 2019
Pioglitazone Reduces β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer's Disease.
Journal: Frontiers in aging neuroscience
Published: January 18, 2019
Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.
Journal: PloS one
Published: September 20, 2012
Cellular and molecular mechanisms underlying the action of ginsenoside Rg1 against Alzheimer's disease.
Journal: Neural regeneration research
Published: June 14, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026